FDA Approves Drug For Rare High Blood Pressure Condition In Lungs
Medical News Today - The US Food and Drug Administration has approved Letairis (chemical name ambrisentan) for treating a rare, life-threatening high blood pressure condition known as pulmonary arterial hypertension (PAH) that affects the arteries of the lungs. Letairis …
